Sox9 regulates hyperexpression of Wnt1 and Fzd1 in human osteosarcoma tissues and cells.
暂无分享,去创建一个
Fengjie Li | Z. Dai | Xin Wang | Yanchun Chen | Shuanhu Zhou | Jie-Xi Ju | Huancai Liu | F. Zhou | Linlin Jie | Leidong Pu
[1] E. Martinelli,et al. Sox9 and Hif-2α regulate TUBB3 gene expression and affect ovarian cancer aggressiveness. , 2014, Gene.
[2] Yu Cai,et al. Wnt Pathway in Osteosarcoma, from Oncogenic to Therapeutic , 2014, Journal of cellular biochemistry.
[3] A. Rashid,et al. SOX9: a useful marker for pancreatic ductal lineage of pancreatic neoplasms. , 2014, Human pathology.
[4] W. Park,et al. Aberrant expression of SOX9 is associated with gastrokine 1 inactivation in gastric cancers , 2014, Gastric Cancer.
[5] Chih-Hsin Tang,et al. Ras activation mediates WISP-1-induced increases in cell motility and matrix metalloproteinase expression in human osteosarcoma. , 2013, Cellular signalling.
[6] Haibo Zhu,et al. Upregulation of SOX9 in osteosarcoma and its association with tumor progression and patients’ prognosis , 2013, Diagnostic Pathology.
[7] T. He,et al. The E-F Hand Calcium-Binding Protein S100A4 Regulates the Proliferation, Survival and Differentiation Potential of Human Osteosarcoma Cells , 2013, Cellular Physiology and Biochemistry.
[8] Olaf Wolkenhauer,et al. Analysing the impact of nucleo-cytoplasmic shuttling of β-catenin and its antagonists APC, Axin and GSK3 on Wnt/β-catenin signalling. , 2013, Cellular signalling.
[9] L. Puskás,et al. Hmgb1 can facilitate activation of the matrilin-1 gene promoter by Sox9 and L-Sox5/Sox6 in early steps of chondrogenesis. , 2013, Biochimica et biophysica acta.
[10] S R Piersma,et al. Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery , 2013, British Journal of Cancer.
[11] Xin Wang,et al. miRNA-9 expression is upregulated in the spinal cord of G93A-SOD1 transgenic mice. , 2013, International journal of clinical and experimental pathology.
[12] Lijun Lin,et al. Synergistic relationship between dipeptidyl peptidase IV and neutral endopeptidase expression and the combined prognostic significance in osteosarcoma patients , 2013, Medical Oncology.
[13] A. Richardson,et al. SOX9 Regulates Low Density Lipoprotein Receptor-related Protein 6 (LRP6) and T-cell Factor 4 (TCF4) Expression and Wnt/β-catenin Activation in Breast Cancer* , 2013, The Journal of Biological Chemistry.
[14] Thomas H. Leung,et al. Down-regulation of Sox7 is associated with aberrant activation of Wnt/β-catenin signaling in endometrial cancer , 2012, Oncotarget.
[15] Xin Wang,et al. Wnt signaling pathway is involved in the pathogenesis of amyotrophic lateral sclerosis in adult transgenic mice , 2012, Neurological research.
[16] Xin Wang,et al. Activation of the Wnt/β-catenin signaling pathway is associated with glial proliferation in the adult spinal cord of ALS transgenic mice. , 2012, Biochemical and biophysical research communications.
[17] Baoan Ma,et al. MicroRNA-34a Inhibits the Proliferation and Metastasis of Osteosarcoma Cells Both In Vitro and In Vivo , 2012, PloS one.
[18] X. Zi,et al. The Wnt signaling pathway: implications for therapy in osteosarcoma , 2011, Expert review of anticancer therapy.
[19] R. Lovell-Badge,et al. Sex determination and the control of Sox9 expression in mammals , 2011, The FEBS journal.
[20] V. Harley,et al. Acquisition of SOX transcription factor specificity through protein-protein interaction, modulation of Wnt signalling and post-translational modification. , 2010, The international journal of biochemistry & cell biology.
[21] A. Zorn,et al. Interactions between SOX factors and Wnt/β‐catenin signaling in development and disease , 2009, Developmental dynamics : an official publication of the American Association of Anatomists.
[22] L. Topol,et al. Sox9 Inhibits Wnt Signaling by Promoting β-Catenin Phosphorylation in the Nucleus* , 2009, Journal of Biological Chemistry.
[23] Aaron M. Zorn,et al. Sox17 and Sox4 Differentially Regulate β-Catenin/T-Cell Factor Activity and Proliferation of Colon Carcinoma Cells , 2007, Molecular and Cellular Biology.
[24] R. Kist,et al. SOX9 is required for maintenance of the pancreatic progenitor cell pool , 2007, Proceedings of the National Academy of Sciences.
[25] Kozo Nakamura,et al. The canonical Wnt signaling pathway promotes chondrocyte differentiation in a Sox9-dependent manner. , 2005, Biochemical and biophysical research communications.
[26] J. Healey,et al. Dickkopf 3 inhibits invasion and motility of Saos-2 osteosarcoma cells by modulating the Wnt-beta-catenin pathway. , 2004, Cancer research.
[27] A. Huvos,et al. Expression of LDL receptor‐related protein 5 (LRP5) as a novel marker for disease progression in high‐grade osteosarcoma , 2004, International journal of cancer.
[28] A. Montag,et al. Cytoplasmic and/or nuclear accumulation of the β‐catenin protein is a frequent event in human osteosarcoma , 2002, International journal of cancer.
[29] R. Teasdale,et al. Twenty pairs of sox: extent, homology, and nomenclature of the mouse and human sox transcription factor gene families. , 2002, Developmental cell.
[30] N. Perrimon,et al. The Promise and Perils of Wnt Signaling Through β-Catenin , 2002, Science.
[31] N. Perrimon,et al. The promise and perils of Wnt signaling through beta-catenin. , 2002, Science.
[32] Sahar Mansour,et al. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene , 1994, Nature.